Salman Ishaqi, spokesperson for the Health and Treatment Commission of the Parliament, addressed the challenges related to the revenues from Iran's gas exports in a webinar meeting of this commission. He referred to new details regarding the management of these revenues and stressed the importance of using them to provide essential goods, especially medicine and medical equipment.
Management of Iran's Gas Export Revenues
Ishaqi explained that the revenues from Iran's gas exports are not directly paid to Tehran and are kept in an account under supervision. He stated that this issue needs to be seriously examined, and the Supreme National Security Council should also take a serious interest in this matter.
Read more: The Golden Time for Medtronic Heart Devices; Unprecedented Growth in Health Technology
According to Ishaqi, the Health and Treatment Commission of the Parliament recently reviewed these revenues and decided that the issue should be forwarded to the Supreme National Security Council and other relevant authorities for follow-up. These actions are aimed at preventing incorrect decisions regarding national resources.
Existing Limitations and Impact on Health-Related Goods Supply
The spokesperson for the Health and Treatment Commission pointed out that the existing limitations on transferring revenues from Iran's gas sales to the country have a direct impact on the supply of essential goods, especially pharmaceutical items and medical equipment. The provision of medicine and medical goods is heavily dependent on access to foreign currency resources and making external payments.
Ishaqi emphasized that, considering the statements from Turkish officials, existing capacities should be utilized to meet pharmaceutical and medical equipment needs. He added that if there is a possibility to use these resources for importing permitted goods, this should be prioritized.
He also highlighted the necessity of considering security concerns in the import of health-related items, stating: "Any medicine and food products entering the country must be carefully and vigilantly monitored. We must pay attention to potential bioterrorism threats from the enemy and act wisely."
In conclusion, Ishaqi stressed that determining the mechanism for using these resources is the responsibility of the government, the Supreme National Security Council, and the heads of the branches, and the Health and Treatment Commission will follow up on this matter as a supervisory body.
Read more: Jim Cramer: J&J's Decisive Choice Over Eli Lilly and Pfizer in the Health World · IRGC Warning; American Warships on the Brink of Tension in the Persian Gulf
